Clinical Trial Update: A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes [NA]

View source ↗

Summary

A completed study compared proton-pump inhibitor test responses in Chinese patients with gastroesophageal reflux disease according to CYP2C19 genotypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: GERD | NA | Status: COMPLETED